3010 C-terminal subdomain in Lon-related proteases catalytic domains
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organosulfur compounds | 2 | 0.2 | 11× | not tested | |
| Organic acids and derivatives | 6 | 1.4 | 4.37× | not tested | |
| Organic nitrogen compounds | 1 | 0.3 | 3.53× | not tested | |
| Homogeneous metal compounds | 3 | 4.4 | 0.69× | not tested | |
| Organic oxygen compounds | 1 | 1.8 | 0.57× | not tested | |
| Homogeneous non-metal compounds | 1 | 1.9 | 0.52× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00188 | BO2 | Bortezomib | 22 |
| DB03345 | BME | Mercaptoethanol | 5 |
| DB00536 | GAI | Guanidine | 4 |
| DB00139 | SIN | Succinic acid | 2 |
| DB03904 | URE | Urea | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| BO2 | N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE | 31 |
| 4KZ | N-[(1R)-1-(dihydroxyboranyl)-2-phenylethyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide | 11 |
| GAI | GUANIDINE | 6 |
| BME | BETA-MERCAPTOETHANOL | 5 |
| CAmetal | CALCIUM ION | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| NAmetal | SODIUM ION | 2 |
| SIN | SUCCINIC ACID | 2 |
| UFY | N-[(1R)-1-borono-3-methylbutyl]-Nalpha-(pyrazine-2-carbonyl)-D-phenylalaninamide | 2 |
| UKS | [(1R)-4-phenyl-1-{[N-(pyrazine-2-carbonyl)-D-norvalyl]amino}butyl]boronic acid | 2 |
| CIX | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-leucinamide | 1 |
| CL | CHLORIDE ION | 1 |
| SLA | Omuralide, open form | 1 |
| URE | UREA | 1 |